Introduction to AlbuRel 20% Infusion
AlbuRel 20% Infusion contains Human Normal Albumin as its active component. It belongs to a class of medications known as plasma expanders. Albumin is a major protein naturally produced by the liver that circulates in the blood plasma. This specialized intravenous solution is indicated for the restoration and maintenance of circulating blood volume in patients with severe albumin deficiencies resulting from conditions such as hypovolemic shock, severe burns, acute respiratory distress syndrome (ARDS), nephrotic syndrome, acute liver failure, or paracentesis associated with hepatic cirrhosis.
AlbuRel works by rapidly increasing the oncotic pressure (colloid osmotic pressure) within the blood vessels. This mechanical pulling force draws interstitial fluid from surrounding body tissues back into the circulatory system. By expanding the blood volume and improving cardiac output, it helps stabilize dropping blood pressure, reduces severe tissue swelling (edema), and ensures vital organs receive an adequate supply of oxygenated blood.
AlbuRel 20% Infusion must be administered exclusively by an intravenous route under the direct supervision of a qualified physician, anesthesiologist, or critical care nurse in a hospital or clinical setting. The infusion rate, volume, and duration of therapy are precisely tailored to the patient’s individual physiological requirements, blood pressure targets, and laboratory parameters.
Before initiating administration, inform your medical team if you have a history of severe anemia, uncompensated heart failure, chronic kidney disease, esophageal varices, or an increased risk of fluid overload (hypervolemia). Seek immediate medical attention if you experience clinical signs of circulatory overload during or after the infusion, such as a sudden headache, breathing difficulties, jugular vein distension, or elevated blood pressure.
Uses of AlbuRel 20% Infusion
Uses of AlbuRel 20% Infusion:
-
Emergent restoration and maintenance of circulating blood volume in cases of volume depletion or hypovolemic shock.
-
Management of severe hypoalbuminemia (low albumin levels) caused by extensive burns, clinical trauma, or major surgical interventions.
-
Assistance in reducing severe fluid retention and abdominal swelling (ascites) in patients undergoing therapeutic paracentesis for liver cirrhosis.
-
Supportive therapy in specialized cases of neonatal hyperbilirubinemia or nephrotic syndrome.
Therapeutic Effects of AlbuRel 20% Infusion
AlbuRel 20% Infusion exerts a high-velocity therapeutic effect by correcting fluid distribution imbalances. Human albumin constitutes approximately 70% to 80% of the total oncotic pressure of normal plasma. Injecting this hyperoncotic solution dramatically expands the vascular volume by pulling extracellular water into the veins, boosting overall blood volume by up to several times the infused amount within minutes. This fluid mobilization elevates systemic blood pressure, lowers high blood viscosity, and clears accumulated tissue fluids, successfully reversing vascular collapse and supporting organ perfusion.
Interaction of AlbuRel 20% Infusion with other drugs
It is important to inform your healthcare professional about all the medications you are taking, including prescription drugs, over-the-counter medications, nutritional supplements, and herbal products. Some medications may interact with AlbuRel 20% Infusion, potentially affecting their effectiveness or causing serious side effects. Notable interactions include:
-
Vasoactive Medications (Inotropes/Vasopressors): When combined with plasma volume expansion, these can trigger a sharp, rapid rise in blood pressure, requiring careful monitoring.
-
Intravenous Solutions: AlbuRel must not be mixed or diluted in the same infusion line with other medicinal solutions, especially whole blood, packed red blood cells, or solutions containing amino acids or alcohol, as this can cause protein clumping (precipitation) or cellular destruction.
More Information about AlbuRel 20% Infusion
-
Keep out of reach of children.
-
Store at a temperature between 2°C and 25°C. Do not freeze, as freezing can crack the glass vial or alter protein structures.
-
Store the vial inside its original outer cardboard carton to protect the solution from direct light exposure.
How to consume AlbuRel 20% Infusion
AlbuRel 20% Infusion is a sterile solution meant for intravenous infusion only. It is delivered directly into a vein through an absolute sterile IV set. It should never be swallowed. The solution must be checked visually before administration; do not use it if it appears cloudy or contains floating particles. Once the vial's sterile seal is broken, the contents must be used immediately, and any unused portion left over must be discarded appropriately to prevent bacterial growth.
Safety Advice for AlbuRel 20% Infusion
Breast Feeding
Consult Your Doctor It is generally safe to administer Human Normal Albumin during breastfeeding if clinically necessary, as albumin is a natural component of human blood. However, consult your physician to evaluate the underlying critical illness before continuing.
Alcohol
Caution Avoid alcohol consumption around the time of your clinical therapy. Alcohol can disrupt blood pressure regulation and place extra stress on a liver that may already be suffering from an underlying pathology.
Liver
Caution While human albumin is naturally synthesized by the liver, advanced liver disease requires precise dosing and fluid monitoring. It is a critical support therapy for liver failure and cirrhosis but must be balanced carefully against portal hypertension risks.
Lungs
High Caution Patients receiving rapid volumes of Albumin infusions face a serious risk of fluid backing up into the lungs (pulmonary edema). Report a sudden wet cough, chest crackles, or extreme breathing difficulties to your care team immediately.
Driving
Consult Your Doctor AlbuRel is administered in emergency or hospital settings for critical volume depletion. Your ability to drive or use machinery will be limited by your underlying medical illness or hospital status, rather than the protein solution itself.
Pregnancy
Consult Your Doctor Human Normal Albumin can be used during pregnancy if explicitly required by your clinical situation. No negative impacts on fetal development are expected, but your obstetrician and critical care team will closely monitor maternal fluid dynamics.
Side Effects of AlbuRel 20% Infusion
Side effects are unwanted symptoms caused by medicines. Although all drugs can cause side effects, not everyone experiences them.
Common side effects of AlbuRel 20% Infusion are:
-
Mild flushing or skin redness
-
Nausea or mild stomach upset
-
Mild fever or chills
-
Temporary increase in heart rate (tachycardia)
-
Mild headaches
Serious side effects of AlbuRel 20% Infusion are:
-
Circulatory Overload / Fluid Overload: (Severe high blood pressure, pounding headache, prominent neck veins, bounding pulse).
-
Pulmonary Edema: (Extreme breathlessness, rapid breathing, coughing up pinkish or frothy sputum).
-
Anaphylactic Shock: (Sudden drop in blood pressure, severe hives, swelling of the throat or face, wheezing, or loss of consciousness).
Word of Advice
During the entire duration of your AlbuRel 20% infusion, your clinical care team will continuously track your vital health lines, including your heart rate, blood pressure, central venous pressure, and respiratory status. Because this solution rapidly shifts fluids inside your body, it is essential to notify your doctor or nurse immediately if you feel a sudden fullness in your chest, an overwhelming headache, or an unexpected wave of dizziness. If your blood pressure rises too quickly, your medical provider will promptly slow down or pause the infusion rate to protect your cardiovascular system.
FAQs about AlbuRel 20% Infusion
Q1. Where does the albumin used in AlbuRel 20% Infusion come from? The albumin in AlbuRel is obtained and isolated from human plasma pools collected from healthy blood donors. The manufacturing process involves advanced viral inactivation, pasteurization, and filtration steps designed to eliminate risks of transmitting viral infections, ensuring a highly purified and safe biological solution.
Q2. How is AlbuRel different from standard intravenous saline solutions? Standard saline solutions (crystalloids) pass through blood vessel walls easily and enter surrounding tissues quickly. AlbuRel contains large, heavy protein molecules (colloids) that cannot easily escape the blood vessels. This allows it to hold fluid inside your veins much longer, making it more effective at raising blood volume and blood pressure.
Q3. Can AlbuRel 20% Infusion cause an allergic reaction? Yes, because it is a human-derived biological product, allergic reactions can occasionally happen. These can range from mild skin rashes and hives to severe, life-threatening anaphylactic shock. If you feel any unusual itching, warmth, or breathing problems during your treatment, alert your care team immediately.
Q4. Why is the infusion speed so tightly monitored by medical staff? If a 20% concentrated albumin solution is infused too quickly, it can pull water into your circulatory system at a speed your heart cannot handle. This sudden fluid surge can cause fluid overload, dangerous high blood pressure, or push fluid directly into your lungs.
Q5. Can I receive AlbuRel 20% Infusion at home? Because this medication is used for acute or critical fluid conditions and carries a high risk of sudden volume overload or allergic reactions, it is almost exclusively given in controlled hospital environments, emergency departments, or specialized clinical daycare centers.
Fact Box of AlbuRel 20% Infusion
-
Molecule name: Human Normal Albumin I.P. (20% Total Protein)
-
Therapeutic class: Plasma Expanders / Intravenous Solutions
-
Pharmacological class: Blood Derivative Colloids
-
Indications: 1. Reversal of hypovolemic shock and volume depletion. 2. Correction of severe hypoalbuminemia from burns or surgeries. 3. Support during large-volume paracentesis for hepatic ascites.
References
-
Vincent JL, et al. Albumin administration in the critically ill. https://pubmed.ncbi.nlm.nih.gov/24515243/
-
Caironi P, et al. Albumin replacement in patients with severe sepsis or septic shock. https://pubmed.ncbi.nlm.nih.gov/24635772/
-
Indian Pharmacopoeia Commission (IPC). Monograph on Human Normal Albumin Infusions. [Updated 2026].
-
Food and Drug Administration (FDA). Albumin (Human) 20% and 25% Concentrated Solutions Prescribing Guidelines. https://www.accessdata.fda.gov/
Disclaimer
Medipoint India’s primary intention is to ensure that its consumers get accurate, trustworthy, and expert-reviewed information. The contents of this website are for informational purposes only and are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on Medipoint India. Our mission is to support, not replace, the doctor-patient relationship.
